AI is transforming global literature review in drug safety by enhancing speed, accuracy, and compliance, enabling faster detection of adverse events and safety signals.

Discover how AI and automation are transforming global literature monitoring in drug safety—boosting efficiency, ensuring timely signal detection, and supporting regulatory compliance for pharmaceutical companies worldwide.